Serviceeinschränkungen vom 12.-22.02.2026 - weitere Infos auf der UB-Homepage

Treffer: Counternull sets in randomized experiments.

Title:
Counternull sets in randomized experiments.
Authors:
Bind MC; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Rubin DB; Yau Center for Mathematical Sciences, Tsinghua University, Beijing, China.; Department of Statistical Science, Temple University, Philadelphia, PA, USA.
Source:
The American statistician [Am Stat] 2025; Vol. 79 (2), pp. 275-285. Date of Electronic Publication: 2025 Jan 17.
Publication Type:
Journal Article
Language:
English
Journal Info:
Publisher: Taylor & Francis Country of Publication: England NLM ID: 0070454 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0003-1305 (Print) Linking ISSN: 00031305 NLM ISO Abbreviation: Am Stat Subsets: PubMed not MEDLINE
Imprint Name(s):
Publication: Abingdon : Taylor & Francis
Original Publication: Washington : American Statistical Assn.
References:
Proc Natl Acad Sci U S A. 2019 May 21;116(21):10329-10332. (PMID: 31064877)
Ann Epidemiol. 2012 May;22(5):364-8. (PMID: 22391267)
Biostatistics. 2024 Oct 1;25(4):1156-1177. (PMID: 38413051)
J Am Stat Assoc. 1986 Dec;81(396):888-901. (PMID: 12155424)
Stat Med. 2019 Sep 20;38(21):4189-4197. (PMID: 31270842)
Stat Methods Med Res. 2019 Jul;28(7):1958-1978. (PMID: 29187059)
Sex Health. 2022 Apr;19(2):79-91. (PMID: 35469589)
Can J Exp Psychol. 2003 Sep;57(3):221-37. (PMID: 14596479)
Psychol Sci. 2021 Sep;32(9):1476-1493. (PMID: 34415205)
N Engl J Med. 2019 Jul 18;381(3):285-286. (PMID: 31314974)
Circulation. 2012 Jul 3;126(1):104-11. (PMID: 22732313)
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19151-19158. (PMID: 32703808)
Soc Psychiatry Psychiatr Epidemiol. 2023 Feb;58(2):277-286. (PMID: 35790563)
Diabetes Obes Metab. 2021 Jul;23(7):1685-1691. (PMID: 33764645)
Biometrics. 2002 Mar;58(1):21-9. (PMID: 11890317)
Am Psychol. 2003 Aug;58(8):554-6. (PMID: 14577186)
Grant Information:
DP5 OD021412 United States OD NIH HHS; R01 AI102710 United States AI NIAID NIH HHS
Contributed Indexing:
Keywords: Fisher-exact p-value; Hypothesis testing; Randomization inference; Randomization-based inference
Entry Date(s):
Date Created: 20250808 Latest Revision: 20260118
Update Code:
20260118
PubMed Central ID:
PMC12326273
DOI:
10.1080/00031305.2024.2432884
PMID:
40777734
Database:
MEDLINE

Weitere Informationen

Consider a study whose primary results are "not statistically significant". How often does it lead to the following published conclusion that "there is no effect of the treatment/exposure on the outcome"? We believe too often and that the requirement to report counternull values could help to avoid this! In statistical parlance, the null value of an estimand is a value that is distinguished in some way from other possible values, for example a value that indicates no difference between the general health status of those treated with a new drug versus a traditional drug. A counternull value is a nonnull value of that estimand that is supported by the same amount of evidence that supports the null value. Of course, such a definition depends critically on how "evidence" is defined. Here, we consider the context of a randomized experiment where evidence is summarized by the randomization-based p-value associated with a specified sharp null hypothesis. Consequently, a counternull value has the same p-value from the randomization test as does the null value; the counternull value is rarely unique, but rather comprises a set of values. We explore advantages to reporting a counternull set in addition to the p-value associated with a null value; a first advantage is pedagogical, in that reporting it avoids the mistake of implicitly accepting a not-rejected null hypothesis; a second advantage is that the effort to construct a counternull set can be scientifically helpful by encouraging thought about nonnull values of estimands. Two examples are used to illustrate these ideas.